LADENBURG THALMANN FINANCIAL SERVICES INC. - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 65 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.3%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$4,000
+300.0%
3,5000.0%0.00%
Q3 2019$1,0000.0%3,5000.0%0.00%
Q2 2019$1,000
-50.0%
3,5000.0%0.00%
Q1 2019$2,000
-66.7%
3,5000.0%0.00%
Q4 2018$6,000
-70.0%
3,5000.0%0.00%
Q3 2018$20,000
-20.0%
3,5000.0%0.00%
Q2 2018$25,0000.0%3,5000.0%0.00%
Q1 2018$25,0000.0%3,5000.0%0.00%
Q4 2017$25,000
+2400.0%
3,500
+3400.0%
0.00%
Q3 2015$1,000
-50.0%
1000.0%0.00%
Q2 2015$2,0001000.00%
Other shareholders

There were no reported owners of TRILLIUM THERAPEUTICS INC in Q1 2020.

NameSharesValueWeighting ↓
View complete list of TRILLIUM THERAPEUTICS INC shareholders